Search Results - "SHROTRIYA, R"

Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression by Robinson, D S, Rickels, K, Feighner, J, Fabre, Jr, L F, Gammans, R E, Shrotriya, R C, Alms, D R, Andary, J J, Messina, M E

“…The azapirone class of anxiolytic drugs is being evaluated for clinical use in the treatment of depression. Buspirone, a serotonin (5-hydroxytryptamine, 5-HT)…”
Get more information

BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies by Saletu, B, Schulz, H, Herrmann, W M, Anderer, P, Shrotriya, R C, Vanbrabant, E

“…In a double-blind, placebo-controlled, cross-over trial, the antihypoxidotic properties of BMS-181168 (previously BMY 21502)--a…”
Get more information

Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögrens syndrome by Papas, A S, Fernandez, M M, Castano, R A, Gallagher, S C, Trivedi, M, Shrotriya, R C

Get more information

Efficacy and safety of BMY 21,502 in Alzheimer disease by Shrotriya, R C, Cutler, N R, Sramek, J J, Veroff, A E, Hironaka, D Y

“…To assess the efficacy and safety of BMY 21,502, a nootropic agent, in patients with mild-to-moderate Alzheimer disease. Sixty-nine patients with Alzheimer…”
Get more information

Serotonergic anxiolytics and treatment of depression by Robinson, D S, Alms, D R, Shrotriya, R C, Messina, M, Wickramaratne, P

“…The serotonin 5-hydroxytryptamine-1A (5-HT1A) receptor agonists buspirone and gepirone have effects on serotonergic systems, including presynaptic and…”
Get more information

Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses by BARBHAIYA, R. H, SHUKLA, U. A, PFEFFER, M, PITTMAN, K. A, SHROTRIYA, R, LAROUDIE, C, GAMMANS, R. E

“…The single dose and steady-state pharmacokinetics of buspirone and its metabolite 1-pyrimidinyl piperazine (1-PP) have been evaluated in normal volunteers and…”
Get full text

Buspirone therapy in anxious elderly patients: a controlled clinical trial by Böhm, C, Robinson, D S, Gammans, R E, Shrotriya, R C, Alms, D R, Leroy, A, Placchi, M

“…Forty patients over 65 years of age with anxiety symptoms due to an anxiety state (N = 20) or secondary to neurotic depression (N = 20) took part in a…”
Get more information

Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG by Bond, A, Lader, M, Shrotriya, R

“…Two doses of buspirone (5 and 10 mg tds), 1 dose of diazepam (5 mg tds) and placebo were administered to 8 normal subjects for a period of 8 days. Each subject…”
Get full text

A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting by Böhm, C, Placchi, M, Stallone, F, Gammans, R E, Alms, D R, Shrotriya, R C, Robinson, D S

“…Sixty patients being treated for anxiety in a primary care facility received (double-blind) buspirone, the benzodiazepine drug clobazam, or placebo for 3…”
Get more information

Buspirone in Parkinson's disease by Hammerstad, J P, Carter, J, Nutt, J G, Casten, G C, Shrotriya, R C, Alms, D R, Temple, D

“…Buspirone, an anxiolytic unrelated to benzodiazepines that may act at the presynaptic dopamine receptor, was given to 11 patients with Parkinson's disease in…”
Get more information

Tofisopam, a novel 3,4-benzodiazepine: multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol by Seppälä, T, Palva, E, Mattila, M J, Korttila, K, Shrotriya, R C

“…Twelve healthy male volunteers were treated (double-blind crossover design) with tofisopam (a new 3,4-benzodiazepine), diazepam, or placebo, on 2 consecutive…”
Get full text

The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease by Cutler, N R, Shrotriya, R C, Sramek, J J, Veroff, A E, Seifert, R D, Reich, L A, Hironaka, D Y

“…BMY 21,502 is a nootropic which protects memory and enhances long-term potentiation according to preclinical findings. Alzheimer's disease (AD) patients who…”
Get more information

Effects of alcohol on buspirone and lorazepam actions by Seppälä, T, Aranko, K, Mattila, M J, Shrotriya, R C

“…Psychomotor and psychologic effects of single doses of buspirone (10 and 20 mg) and lorazepam (2.5 mg) alone or combined with alcohol (1 gm/kg) were…”
Get more information

Local Time-Temperature-Dependent Deformation of a Woven Composite by Shrotriya, P.

Get full text

Serum prolactin levels after buspirone in man by Seppälä, T, Ranta, T, Shrotriya, R C

“…The acute effects of buspirone, an anxiolytic with mixed dopamine (DA) agonist-antagonist properties (achieved by blocking pre- and postsynaptic receptors) on…”
Get more information

Treatment of panic disorder: nonbenzodiazepine anxiolytics, including buspirone by Robinson, D S, Shrotriya, R C, Alms, D R, Messina, M, Andary, J

Get more information

Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group by Nelson, J D, Friedlaender, M, Yeatts, R P, Yee, R, McDermott, M, Orlin, S, Gallagher, S C, Shrotriya, R C

Get more information